Clinical trial Recruiting at 1 site Interventional Ages 18 to 24

Effects of a cellphone app on young drivers' behavior

Official title: Randomized Trial on Mobile Technology and Young Drivers' Cellphone Use

Run by Nationwide Children's Hospital · NCT05163119 · Data updated 2026-11-12

This study tests whether a cellphone-blocking app can help young drivers aged 18-24 drive safer by reducing their phone use while driving.

Quick facts

Study typeInterventional
Ages18 Years to 24 Years
SexAll
Enrollment1200 (estimated)
SponsorNationwide Children's Hospital
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedNovember 9, 2022
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT05163119 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are young adults aged 18-24 who frequently use their cellphones while driving and reside in the Greater Columbus area.

Probably not a fit

Patients who are under 18 years of age or those who do not regularly drive may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of a cellphone-blocking app and a driving mode intervention on the driving behavior of young adults aged 18-24. A total of 1200 participants will be randomly assigned to one of three groups for a duration of six months. The researchers aim to assess how these interventions affect cellphone use while driving and the occurrence of high-risk driving events. The study will provide insights into the effectiveness of mobile technology in promoting safer driving habits among young drivers.

Why it matters

Potential benefit: If successful, this study could lead to improved driving safety and reduced accidents among young drivers by minimizing cellphone distractions.

How similar studies have gone: Other studies have shown promising results with similar interventions aimed at reducing cellphone use while driving, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults 18-24 years of age at time of recruitment
* Must have ownership and exclusive access to a passenger vehicle
* Must have car insurance with at least state-minimum coverage
* Must live in Greater Columbus (Ohio) area
* Must drive at least 2 days a week on average
* Must have functioning iPhone or Android smartphone with an active phone service account (Ex: Verizon, AT\&T, etc.)
* Must self-report handheld calling or texting while driving (≥ 1 time/week)
* Must not be enrolled in another driving-related research study during the study period.
* Must be willing to be randomized and comply with study requirements
* Must have no plans to change cellphones or vehicles in next 6 months or agree to transfer FleetSafer app/DriveCam if they change cellphones or vehicles
* Must speak and read English

Exclusion Criteria:

* Drivers under 18 years of age
* Drivers holding learner's permits
* Drivers who share a vehicle with a family member or others
* Infrequent drivers (Drive 2 days a week or less)
* Participants from the pilot R21 project
* Current users of a cellphone-blocking app or driving mode who do not agree to uninstall/de-activate the app for the duration of participation in the study
* Current users of a car insurance monitoring device (physical device or app)

Where it's running

  • Nationwide Children's Hospital
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Transauricular Neurostimulation for Abdominal Pain in Teens

    We are testing a head- and ear‑based device to see if it helps teens with abdominal pain from gut-brain disorders.

    Recruiting Nationwide Children's Hospital · Columbus, Ohio · NCT07798180

  • MedMemos: helping families stick to medications after pediatric stem cell transplant

    MedMemos tests a caregiver-focused program to help families of children who had a bone marrow transplant take medications more consistently.

    Recruiting Nationwide Children's Hospital · Columbus, Ohio · NCT07718204

  • Light therapy for children in the pediatric ICU

    This project will try daily bedside light therapy for children aged 4–17 in the pediatric ICU to see how easy it is to deliver and whether patients, families, and staff tolerate it.

    Recruiting Nationwide Children's Hospital · Columbus, Ohio · NCT07384585

  • Food is Medicine program to boost family heart health

    The trial tests whether providing healthy food access plus personalized digital tools and coaching can improve heart health for families with a parent on Medicaid and a 6–11 year old child.

    Recruiting Nationwide Children's Hospital · Columbus, Ohio · NCT07380243

  • AI-based personalized health and self-care support for caregivers of children

    This pilot will test whether the DAPHNE chatbot helps caregivers of children with unmet social needs connect to community resources, stay engaged, and fit into primary care workflows over six months.

    Recruiting Nationwide Children's Hospital · Columbus, Ohio · NCT07168382

  • Caregiver questionnaire on firearm ownership and safety

    We will ask parents and legal guardians of children having surgery at Nationwide Children's Hospital about firearm ownership, storage, access, and safety education to see if common safety practices are followed.

    Recruiting Nationwide Children's Hospital · Columbus, Ohio · NCT07155083

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.